CSS
PASG icon

Cubist Systematic Strategies’s Passage Bio PASG Stock Holding History

Cubist Systematic Strategies’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-565
Closed -$15.2K – 3761
2024
Q1 		$15.2K Buy
+565
New +$13.6K ﹤0.01% 3489
2023
Q2 		– Sell
-506
Closed -$9.7K – 4097
2023
Q1 		$9.7K Sell
506
-198
-28% -$5.37K ﹤0.01% 3725
2022
Q4 		$19.4K Sell
704
-1,257
-64% -$31.7K ﹤0.01% 3995
2022
Q3 		$49K Sell
1,961
-920
-32% -$36.3K ﹤0.01% 4135
2022
Q2 		$136K Sell
2,881
-274
-9% -$12.8K ﹤0.01% 3855
2022
Q1 		$196K Buy
3,155
+698
+28% +$57.5K ﹤0.01% 3053
2021
Q4 		$312K Buy
2,457
+1,232
+101% +$201K ﹤0.01% 2769
2021
Q3 		$244K Sell
1,225
-942
-43% -$225K ﹤0.01% 2475
2021
Q2 		$574K Buy
2,167
+1,629
+303% +$504K 0.01% 1917
2021
Q1 		$188K Buy
+538
New +$230K ﹤0.01% 2497

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Cubist Systematic Strategies's PASG Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of Passage Bio (PASG) in Q2 2024, closing a stake of 565 shares — an estimated $15.2K sold.

Cubist Systematic Strategies first reported a position in PASG in Q1 2021 and held it in 10 quarters. The position peaked at $574K in Q2 2021. 43 funds tracked by Wall St. Rank hold PASG as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining Passage Bio position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 565 Passage Bio shares in Q2 2024, an estimated $15.2K.
  • Cubist Systematic Strategies first reported a position in Passage Bio in Q1 2021 and held it in 10 quarters.
  • Cubist Systematic Strategies's Passage Bio position peaked at $574K in Q2 2021.
  • 43 funds tracked by Wall St. Rank held Passage Bio as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.